$10.42
al cierre: Nov 11 EDT
$10.39
-0.03-0.29%
Pre-comercialización: 5:48 PM EDT
Comments
Loading...
NeoGenomics Actividad de operaciones con información privilegiada
NEONASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de NeoGenomics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de NeoGenomics.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo NeoGenomics Inc los iniciados?
En NeoGenomics Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de 4.92K acciones por valor de $49.18K, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El octubre 20, 2025, Alicia C Olivo, la empresa EVP, GC & BUSINESS DEVELOPMENT sold 4.92K acciones por $10 cada una.
Estadísticas de propiedad de NeoGenomics Inc
Acciones en circulación
129.388M
Acciones en manos de personas con información privilegiada
7.098M
Porcentaje de acciones en manos de personas con información privilegiada
5.49%
Acciones en manos de instituciones
71.622M
Porcentaje de acciones en manos de instituciones
55.4%
Oct 20, 2025 | EVP, GC & BUSINESS DEVELOPMENT | -4.92K | $10.00 | -$49.18K | SELL | -10.26% | 43.02K | Oct 16 | ||
Aug 06, 2025 | CHIEF FINANCIAL OFFICER | 20.00K | $5.62 | $112.32K | BUY | 11.88% | 188.33K | Aug 06 | ||
Aug 06, 2025 | CHIEF EXECUTIVE OFFICER | 17.90K | $5.58 | $99.95K | BUY | 45.82% | 56.97K | Aug 06 | ||
May 28, 2025 | DIRECTOR | 5.00K | $7.60 | $38.00K | BUY | 15.75% | 36.76K | May 27 | ||
May 13, 2025 | PRES & CHIEF OPERATING OFFICER | 12.97K | $8.58 | $48.89K | BUY | 13.61% | 108.28K | May 11 - May 12 | ||
May 09, 2025 | DIRECTOR | 7.00K | $8.14 | $56.97K | BUY | 11.40% | 68.40K | May 09 | ||
May 09, 2025 | DIRECTOR | 4.00K | $7.78 | $31.12K | BUY | 11.08% | 40.09K | May 07 | ||
May 08, 2025 | CHIEF EXECUTIVE OFFICER | 18.90K | $7.88 | $148.92K | BUY | 166.73% | 30.24K | May 06 | ||
May 07, 2025 | DIRECTOR | 10.00K | $7.63 | $76.30K | BUY | 46.22% | 31.64K | May 05 | ||
May 07, 2025 | DIRECTOR | 4.51K | $7.75 | $34.98K | BUY | 39.79% | 15.85K | May 05 | ||
May 06, 2025 | CHIEF FINANCIAL OFFICER | 20.00K | $7.51 | $150.10K | BUY | 14.44% | 158.49K | May 02 | ||
Nov 19, 2024 | GENERAL COUNSEL | -5.17K | $15.36 | -$79.48K | SELL | -12.23% | 37.13K | Nov 15 | ||
Aug 19, 2024 | GENERAL COUNSEL | -1.04K | $16.05 | -$16.70K | SELL | -2.32% | 43.81K | Aug 15 | ||
May 17, 2024 | GENERAL COUNSEL | -1.05K | $15.74 | -$16.51K | SELL | -2.28% | 44.87K | May 15 | ||
Mar 06, 2024 | DIRECTOR | -6.11K | $15.97 | -$97.58K | SELL | -10.88% | 50.06K | Mar 04 | ||
Feb 20, 2024 | GENERAL COUNSEL | -2.59K | $14.96 | -$38.71K | SELL | -6.91% | 34.87K | Feb 15 | ||
Nov 20, 2023 | GENERAL COUNSEL | -2.67K | $18.39 | -$49.08K | SELL | -6.70% | 37.14K | Nov 17 | ||
Mar 09, 2022 | CHIEF FINANCIAL OFFICER | 1.79K | $12.90 | -$21.09K | SELL-OPTIONS | 1.76% | 103.52K | Mar 07 - Mar 08 | ||
Dec 23, 2021 | CHIEF FINANCIAL OFFICER | 3.15K | $22.04 | -$19.26K | SELL-OPTIONS | 23.30% | 16.69K | Dec 21 - Dec 22 | ||
Dec 06, 2021 | CHIEF EXECUTIVE OFFICER | 17.00K | $30.63 | $520.71K | BUY | 30.50% | 72.74K | Dec 06 | ||
Nov 29, 2021 | PRESIDENT, INFORMATICS | 0.00 | $22.58 | -$727.50K | SELL-OPTIONS | 0.00% | 15.47K | Nov 24 | ||
Nov 26, 2021 | CHIEF STRATEGY OFFICER | -100.00K | $36.96 | -$3.70M | SELL | -89.57% | 11.64K | Nov 23 - Nov 26 | ||
Jun 10, 2021 | DIRECTOR | 0.00 | $28.02 | -$557.39K | SELL-OPTIONS | 0.00% | 49.56K | Jun 08 | ||
Jun 04, 2021 | PRESIDENT, PHARMA SERVICES | -200.34K | $40.35 | -$8.08M | SELL | -50.45% | 196.77K | Jun 02 - Jun 03 | ||
May 27, 2021 | PRESIDENT, CLINICAL SERVICES | -3.65K | $25.56 | -$3.64M | SELL | -2.37% | 150.10K | May 25 | ||
Dec 15, 2020 | — | 88.80K | $30.23 | -$6.43K | OPTION EXERCISE | 757.91% | 100.52K | Dec 14 | ||
Dec 14, 2020 | — | -70.00K | $50.87 | -$3.56M | SELL | -6.12% | 1.07M | Dec 10 - Dec 14 | ||
Dec 11, 2020 | — | 0.00 | $29.01 | -$629.40K | OPTION EXERCISE | 0.00% | 24.98K | Dec 11 | ||
Dec 07, 2020 | DIRECTOR | -130.00K | $48.55 | -$6.31M | SELL | -10.21% | 1.14M | Dec 03 - Dec 07 | ||
Dec 07, 2020 | — | -24.68K | $47.88 | -$1.18M | SELL | -44.34% | 30.98K | Dec 04 | ||
Dec 04, 2020 | — | 0.00 | $27.41 | -$310.16K | OPTION EXERCISE | 0.00% | 12.06K | Dec 02 | ||
Nov 25, 2020 | — | 20.00K | $26.44 | -$4.77M | OPTION EXERCISE | 5.39% | 390.90K | Nov 24 - Nov 25 | ||
Nov 18, 2020 | — | -70.00K | $42.28 | -$2.96M | SELL | -51.17% | 66.80K | Nov 16 | ||
Nov 16, 2020 | — | 160.00K | $24.77 | -$10.52M | OPTION EXERCISE | 7.02% | 2.44M | Nov 12 - Nov 16 | ||
Nov 12, 2020 | — | 12.74K | $24.93 | $22.75K | OPTION EXERCISE | 28.96% | 56.73K | Nov 10 | ||
Sep 30, 2020 | — | -305.00K | $36.72 | -$10.28M | GIFT | -72.85% | 113.69K | Sep 28 - Sep 29 | ||
Sep 24, 2020 | — | -2.40K | $22.13 | -$301.46K | OPTION EXERCISE | -4.91% | 46.48K | Sep 22 - Sep 24 | ||
Sep 10, 2020 | — | -120.00K | $36.95 | -$4.43M | SELL | -7.07% | 1.58M | Sep 08 - Sep 10 | ||
Aug 10, 2020 | — | 17.50K | $23.25 | -$2.53M | OPTION EXERCISE | 4.95% | 370.90K | Aug 06 | ||
Aug 04, 2020 | — | 0.00 | $23.09 | -$682.98K | OPTION EXERCISE | 0.00% | 12.06K | Aug 03 | ||
Aug 04, 2020 | — | 0.00 | $23.38 | -$412.49K | OPTION EXERCISE | 0.00% | 24.98K | Aug 03 | ||
Aug 03, 2020 | — | 2.04K | $24.06 | -$2.28M | OPTION EXERCISE | 1.39% | 148.27K | Jul 30 | ||
Mar 05, 2020 | — | -1.93K | $19.45 | -$2.25M | OPTION EXERCISE | -1.25% | 151.64K | Mar 04 | ||
Mar 04, 2020 | — | -297.30K | $28.77 | -$8.55M | SELL | -56.84% | 225.71K | Mar 02 | ||
Dec 12, 2019 | CHIEF ACCOUNTING OFFICER | 0.00 | $17.20 | -$146.72K | SELL-OPTIONS | 0.00% | 2.27K | Dec 10 | ||
Nov 22, 2019 | DIRECTOR | -201.23K | $24.39 | -$4.91M | SELL | -45.02% | 245.71K | Nov 20 - Nov 21 | ||
Nov 21, 2019 | CHAIRMAN AND CEO | -187.50K | $24.08 | -$4.51M | SELL | -7.59% | 2.28M | Nov 19 | ||
Nov 18, 2019 | VP AND CHIEF CULTURE OFFICER | 0.00 | $15.49 | -$108.77K | SELL-OPTIONS | 0.00% | 22.86K | Nov 15 | ||
Nov 14, 2019 | PRESIDENT, PHARMA SERVICES | 25.00K | $15.15 | -$132.35K | SELL-OPTIONS | 8.31% | 325.83K | Nov 12 | ||
Nov 08, 2019 | PRESIDENT, PHARMA SERVICES | 0.00 | $14.98 | -$870.48K | SELL-OPTIONS | 0.00% | 300.83K | Nov 06 - Nov 07 | ||
Nov 04, 2019 | PRESIDENT, CLINICAL SERVICES | -10.11K | $15.51 | -$1.67M | SELL | -6.49% | 145.64K | Oct 31 - Nov 01 | ||
Sep 10, 2019 | DIRECTOR | -6.29K | $23.54 | -$68.11K | SELL | -6.30% | 93.53K | Sep 06 - Sep 10 | ||
Aug 30, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $16.17 | -$294.27K | SELL-OPTIONS | 0.00% | 6.74K | Aug 28 | ||
Aug 30, 2019 | DIRECTOR | -40.74K | $25.02 | -$1.02M | SELL | -2.30% | 1.73M | Aug 28 - Aug 30 | ||
Aug 27, 2019 | DIRECTOR | -6.90K | $17.03 | -$312.85K | SELL | -4.89% | 134.10K | Aug 23 - Aug 26 | ||
Aug 27, 2019 | DIRECTOR | -53.00K | $25.41 | -$1.35M | SELL | -65.20% | 28.29K | Aug 23 - Aug 26 | ||
Aug 27, 2019 | DIRECTOR | -181.34K | $24.92 | -$4.52M | SELL | -9.30% | 1.77M | Aug 23 - Aug 27 | ||
May 09, 2019 | DIRECTOR | -150.00K | $22.41 | -$3.36M | SELL | -52.16% | 137.58K | May 07 - May 08 | ||
May 08, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $15.53 | -$115.27K | SELL-OPTIONS | 0.00% | 6.74K | May 06 | ||
May 06, 2019 | VP AND CHIEF CULTURE OFFICER | 0.00 | $15.03 | -$462.77K | SELL-OPTIONS | 0.00% | 22.86K | May 02 - May 03 | ||
May 06, 2019 | PRESIDENT, CLINICAL SERVICES | 13.99K | $14.74 | -$1.66M | SELL-OPTIONS | 9.43% | 162.31K | May 02 | ||
May 06, 2019 | PRESIDENT, PHARMA SERVICES | 48.32K | $13.80 | -$2.51M | SELL-OPTIONS | 17.73% | 320.83K | May 02 - May 03 | ||
Mar 04, 2019 | VP AND CHIEF CULTURE OFFICER | 2.86K | $13.61 | -$511.24K | SELL-OPTIONS | 14.31% | 22.86K | Feb 28 - Mar 04 | ||
Feb 28, 2019 | EXECUTIVE VICE PRESIDENT | -299.87K | $18.90 | -$5.67M | SELL | -75.34% | 98.13K | Feb 26 - Feb 27 | ||
Feb 28, 2019 | PRESIDENT, CLINICAL SERVICES | 13.99K | $13.12 | -$2.07M | SELL-OPTIONS | 11.33% | 137.38K | Feb 26 - Feb 28 | ||
Feb 28, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $13.38 | -$664.63K | SELL-OPTIONS | 0.00% | 0.00 | Feb 26 | ||
Feb 28, 2019 | DIRECTOR | 0.00 | $12.70 | -$234.36K | SELL-OPTIONS | 0.00% | 287.58K | Feb 26 | ||
Dec 26, 2018 | DIRECTOR | 26.00K | $11.60 | $301.60K | BUY | 33.39% | 103.87K | Dec 21 | ||
Dec 14, 2018 | — | -10.84M | $12.00 | -$130.02M | SELL | -100.00% | 0.00 | Dec 14 | ||
Nov 21, 2018 | DIRECTOR | -13.00K | $16.00 | -$207.94K | SELL | -25.37% | 38.23K | Nov 19 | ||
Nov 16, 2018 | DIRECTOR | 13.89K | $11.82 | $60.64K | SELL-OPTIONS | 37.19% | 51.23K | Nov 14 - Nov 15 | ||
Nov 14, 2018 | EXECUTIVE VICE PRESIDENT | -141.13K | $16.66 | -$2.35M | SELL | -37.55% | 234.75K | Nov 12 - Nov 14 | ||
Nov 13, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $10.83 | -$986.66K | SELL-OPTIONS | 0.00% | 20.00K | Nov 09 - Nov 12 | ||
Nov 13, 2018 | 10% OWNER | -4.16M | $16.75 | -$69.76M | SELL | -27.77% | 10.84M | Nov 09 | ||
Nov 13, 2018 | DIRECTOR | -66.01K | $17.03 | -$1.12M | SELL | -45.88% | 77.87K | Nov 09 | ||
Nov 13, 2018 | PRESIDENT, CLINICAL SERVICES | 83.51K | $10.90 | -$2.24M | SELL-OPTIONS | 209.37% | 123.39K | Nov 09 - Nov 12 | ||
Aug 01, 2018 | EXECUTIVE VICE PRESIDENT | -203.50K | $14.00 | -$2.85M | SELL | -7.97% | 2.35M | Jul 30 - Aug 01 | ||
Jun 29, 2018 | PRESIDENT, CLINICAL SERVICES | -12.94K | $13.12 | -$169.79K | SELL | -24.50% | 39.88K | Jun 29 | ||
Jun 26, 2018 | EXECUTIVE VICE PRESIDENT | -89.69K | $14.04 | -$1.26M | SELL | -3.40% | 2.55M | Jun 22 | ||
Jun 19, 2018 | EXECUTIVE VICE PRESIDENT | -160.31K | $13.32 | -$2.13M | SELL | -5.72% | 2.64M | Jun 15 - Jun 19 | ||
Jun 05, 2018 | EXECUTIVE VICE PRESIDENT | -223.64K | $12.12 | -$2.79M | SELL | -7.40% | 2.80M | Jun 01 | ||
May 31, 2018 | EXECUTIVE VICE PRESIDENT | -169.47K | $11.68 | -$1.98M | SELL | -5.29% | 3.03M | May 29 - May 31 | ||
May 31, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $8.22 | -$447.40K | SELL-OPTIONS | 0.00% | 13.32K | May 29 | ||
May 17, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $8.01 | -$83.92K | SELL-OPTIONS | 0.00% | 0.00 | May 15 | ||
May 10, 2018 | CIO | 0.00 | $8.53 | -$369.43K | SELL-OPTIONS | 0.00% | 9.00K | May 10 | ||
Jul 31, 2017 | DIRECTOR | 20.00K | $9.19 | $183.80K | BUY | 106.48% | 38.78K | Jul 27 | ||
Jun 26, 2017 | VP AND CHIEF CULTURE OFFICER | -10.72K | $8.49 | -$91.04K | SELL | -100.00% | 0.00 | Jun 22 | ||
Jun 06, 2017 | CIO | 0.00 | $6.04 | -$242.68K | SELL-OPTIONS | 0.00% | 9.00K | Jun 02 - Jun 05 | ||
May 30, 2017 | VP AND CHIEF CULTURE OFFICER | -3.33K | $7.50 | -$25.00K | SELL | -24.91% | 10.05K | May 26 | ||
Mar 22, 2017 | PRESIDENT, PHARMA SERVICES | -50.00K | $7.93 | -$396.65K | SELL | -75.81% | 15.95K | Mar 13 - Mar 20 | ||
Mar 17, 2017 | PRESIDENT, PHARMA SERVICES | 16.55K | $8.00 | $132.40K | s | 50.38% | 49.40K | Mar 13 | ||
Sep 27, 2016 | CHIEF MEDICAL OFFICER | -2.80K | $8.40 | -$23.52K | SELL | -2.21% | 124.18K | Sep 23 | ||
Sep 22, 2016 | CHIEF MEDICAL OFFICER | -105.30K | $8.20 | -$863.46K | SELL | -50.00% | 105.30K | Sep 20 | ||
Sep 13, 2016 | CHIEF MEDICAL OFFICER | -60.08K | $8.23 | -$494.12K | SELL | -18.16% | 270.68K | Sep 09 - Sep 12 | ||
Aug 23, 2016 | CHIEF MEDICAL OFFICER | 165.38K | $5.16 | -$2.14M | SELL-OPTIONS | 130.23% | 292.36K | Aug 19 | ||
May 27, 2016 | CHAIRMAN AND CEO | 0.00 | $5.21 | -$4.20M | SELL-OPTIONS | 0.00% | 3.35M | May 25 - May 27 | ||
May 20, 2016 | CIO | 0.00 | $6.64 | -$66.96K | SELL-OPTIONS | 0.00% | 9.00K | May 18 | ||
May 10, 2016 | CIO | 0.00 | $6.50 | -$51.60K | SELL-OPTIONS | 0.00% | 9.00K | May 09 | ||
May 03, 2016 | EXECUTIVE VP FINANCE | -177.75K | $8.21 | -$1.46M | SELL | -42.33% | 242.16K | May 02 - May 03 | ||
May 03, 2016 | CIO | 0.00 | $6.02 | -$470.25K | SELL-OPTIONS | 0.00% | 4.50K | Apr 29 | ||
Mar 14, 2016 | CHIEF FINANCIAL OFFICER | 68.00K | $4.14 | -$72.56K | SELL-OPTIONS | 48.20% | 209.09K | Mar 11 | ||
Mar 10, 2016 | CHAIRMAN AND CEO | 550.00K | $3.95 | -$2.39M | SELL-OPTIONS | 41.90% | 1.86M | Mar 08 - Mar 09 | ||
Mar 07, 2016 | DIRECTOR | 22.01K | $6.78 | $149.20K | BUY | 24.86% | 110.55K | Mar 03 - Mar 04 | ||
Mar 04, 2016 | DIRECTOR | 10.00K | $6.90 | $69.00K | BUY | 641.03% | 11.56K | Mar 03 | ||
Dec 23, 2015 | DIRECTOR | 9.50K | $8.21 | $78.00K | BUY | 187.75% | 14.56K | Dec 21 | ||
Dec 09, 2015 | DIRECTOR | 3.50K | $7.72 | $27.02K | BUY | 224.36% | 5.06K | Dec 07 | ||
Dec 04, 2015 | CHIEF OPERATING OFFICER | 6.55K | $7.75 | $50.76K | BUY | ∞ | 6.55K | Dec 03 | ||
Nov 27, 2015 | EXECUTIVE VP FINANCE | -410.00K | $8.09 | -$3.32M | SELL | -46.26% | 476.25K | Nov 25 - Nov 27 | ||
Nov 04, 2015 | DIRECTOR | 6.40K | $7.81 | $49.98K | BUY | 178.77% | 9.98K | Nov 02 | ||
Dec 22, 2014 | VICE PRESIDENT ANDGM PATHLOGIC | 0.00 | $2.78 | -$92.57K | SELL-OPTIONS | 0.00% | 0.00 | Dec 19 | ||
Dec 19, 2014 | VICE PRESIDENT ANDGM PATHLOGIC | 0.00 | $2.82 | -$173.62K | SELL-OPTIONS | 0.00% | 0.00 | Dec 18 | ||
Dec 08, 2014 | DIRECTOR | -11.80K | $4.50 | -$53.10K | SELL | -0.64% | 1.82M | Dec 04 | ||
Dec 01, 2014 | CHIEF FINANCIAL OFFICER | 70.00K | $2.91 | -$55.27K | SELL-OPTIONS | 98.47% | 141.09K | Nov 26 | ||
Nov 24, 2014 | DIRECTOR | -33.20K | $4.51 | -$149.71K | SELL | -1.78% | 1.83M | Nov 20 - Nov 21 | ||
Aug 27, 2014 | DIRECTOR | -300.00K | $3.00 | -$900.00K | SELL | -15.26% | 1.67M | Mar 05 | ||
May 27, 2014 | CHIEF SCIENCE OFFICER | 0.00 | $1.87 | -$324.16K | SELL-OPTIONS | 0.00% | 8.44K | May 22 | ||
May 21, 2014 | CHIEF SCIENCE OFFICER | -10.00K | $3.65 | -$36.53K | SELL | -54.23% | 8.44K | May 19 | ||
Mar 31, 2014 | CHIEF MEDICAL OFFICER | 14.49K | $3.51 | $50.85K | BUY | 29.58% | 63.49K | Mar 28 | ||
Dec 18, 2013 | CHIEF SCIENCE OFFICER | -646.00 | $3.74 | -$2.42K | SELL | -3.38% | 18.44K | Dec 17 | ||
Dec 17, 2013 | CHIEF SCIENCE OFFICER | -5.67K | $3.68 | -$20.88K | SELL | -22.91% | 19.09K | Dec 12 | ||
Dec 11, 2013 | CHIEF SCIENCE OFFICER | -20.10K | $3.70 | -$74.37K | SELL | -44.81% | 24.76K | Dec 10 - Dec 11 | ||
Dec 09, 2013 | CHIEF FINANCIAL OFFICER | 0.00 | $2.60 | -$42.20K | GRANT | 0.00% | 71.09K | Dec 09 | ||
Dec 06, 2013 | CHIEF SCIENCE OFFICER | -33.00K | $3.67 | -$121.10K | SELL | -42.38% | 44.86K | Dec 05 | ||
Dec 04, 2013 | CHIEF SCIENCE OFFICER | 67.85K | $1.96 | -$92.92K | GRANT | 678.54% | 77.85K | Dec 02 - Dec 03 | ||
Nov 26, 2013 | EXECUTIVE VP FINANCE | -112.97K | $3.58 | -$404.75K | SELL | -2.85% | 3.85M | Nov 22 - Nov 25 | ||
May 08, 2013 | CHIEF SCIENCE OFFICER | -2.50K | $3.60 | -$9.00K | SELL | -20.00% | 10.00K | May 02 | ||
May 01, 2013 | CHIEF SCIENCE OFFICER | 12.50K | $2.00 | -$127.95K | GRANT | ∞ | 12.50K | Apr 29 - May 01 | ||
May 01, 2013 | EXECUTIVE VP FINANCE | -100.00K | $3.71 | -$371.15K | SELL | -2.60% | 3.74M | Apr 29 - Apr 30 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.